Diazyme HbA1c Point of Care Assay Receives FDA Clearance

Diazyme Laboratories (San Diego, CA) has received FDA clearance for its SMART HbA1c Assay on the SMART Point of Care System for diabetes monitoring. HbA1c or glycated hemoglobin is, of course, a measure of long-time blood glucose control, with its level proportional to average blood glucose concentration over the previous one to three months. The system allows for fast in-office determination of the HbA1c level from a finger stick blood sample. One of the distinguishing features of this test compared to the rest of the market is that it is insensitive to most hemoglobin variants, including Hb E, Hb C, Hb S and Hb D. It uses the fructosyl valine oxidase enzyme and an optical detector to measure the HbA1c level without the need for a separate total hemoglobin measurement. Other tests in development for the SMART system include cystatin C, enzymatic homocysteine and high sensitivity hsCRP.Press release:Diazyme Receives FDA 510(k) Clearance to Market SMART HbA1c Assay on Its SMART Point of Care System for Diabetes Monitoring…Product page:Direct HbA1c Point of Care…

Wouter Stomp is a radiology resident at the radiology department of Leiden University Medical Center, the Netherlands. He is also a PhD candidate with his research focussing on the role of MRI in early rheumatoid arthritis.

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around

more

Event Details

PULSUS group cordially welcomes researchers, academicians, students and business professionals in the field of Cancer Science and Therapy from around the world to participate in the upcoming “2nd World Congress on Advanced Cancer Science & Therapy” to be held at Dubai, UAE during January 28-29, 2019. The meeting for this year will revolve around the theme “An Assembly of Curious Facts and Cure for Cancer” thus relaying the most cutting-edge findings in this field.

The two-day meeting is going to be an event to look forward for its enlightening symposiums & workshops from established experts in cancer therapy, potential keynote talks from eminent speakers, informative oral sessions and innovative poster presentations.

Cancer Therapy 2019 is an extraordinary event that invites participants from different leading universities, clinical research institutions and various diagnostic companies to share their research experiences in all aspects of this rapidly expanding field and provides an opportunity to meet and communicate with leading doctors, surgeons, scientists, academic professionals from around the world and listen to top speakers on new developments that impact and advance future of cancer science. It serves as a global platform to know about the current developments and new approaches in the field of cancer science and therapy. It will also prove to be a brilliant open door for businesses keen on expanding their global market reach. This event is an effort to understand the underlying new techniques which are amended to increase effectiveness, accuracy, sustainability, and quality of life.